Sumathi Sundaravadivelu

Dr. Sumathi Sundaravadivelu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
SSSumathi Sundaravadivelu
Sumathi Sundaravadivelu
KSKanagaraj Suganya
Kanagaraj Suganya
KSKandasamy Swathi
Kandasamy Swathi
BSBalraj Sudha
Balraj Sudha
APArumugam Poornima
Arumugam Poornima
RARaghu Aswathy
Raghu Aswathy
It takes an average of 10-15 years to uncover and develop a new drug, and the process is incredibly time-consuming, expensive, difficult, and ineffective. In recent years the dramatic changes in the field of artificial intelligence (AI) have helped to overcome the challenges in the drug discovery pipeline. Artificial intelligence (AI) has taken root in various pharmaceutical sectors, from lead compound identification to clinical trials. Deep learning (DL) is a component of artificial intelligence (AI) that has excelled in many fields of Artificial intelligence (AI) research over the past decades. Its numerous applications in the realms of science and technology, especially in biomedicine and bioinformatics, are witnessed deep learning (DL) applications significantly accelerate drug discovery and pharmaceutical research in recent years, and their usefulness has exceeded expectations and shown good promise in tackling a range of issues with drug discovery. Deep learning (DL) holds great potential for drug development since it allows for sophisticated image interpretation, molecular structure and function prediction, and the automated creation of novel chemical entities with specific features. In the process of drug discovery, deep learning (DL) can be incorporated at all stages like identification of targets, prognostic biomarkers, drug designing and development, synergism and antagonism prediction, etc. This review summarizes various approaches of deep learning (DL) in drug discovery like deep generative models for drug discovery, deep learning (DL) tools for drug discovery, synergy prediction, and precision medicine.

17 December 2024 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
RARaghu Aswathy
Raghu Aswathy
VCVarghese Angel Chalos
Varghese Angel Chalos
KSKanagaraj Suganya
Kanagaraj Suganya
SSSumathi Sundaravadivelu
Sumathi Sundaravadivelu

29 September 2021 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
PAPoornima Arumugam
Poornima Arumugam
BSBanupriya Sampathkumar
Banupriya Sampathkumar
HPHaribalan Perumalsamy
Haribalan Perumalsamy
SBSri Renukadevi Balusamy
Sri Renukadevi Balusamy
VRVignesh Ramesh
Vignesh Ramesh
SSSumathi Sundaravadivelu
Sumathi Sundaravadivelu


16 November 2024 in Current Problems in Cancer
Verified
Journal Article
Closed access
BSBalraj Sudha
Balraj Sudha
NKNachimuthu Senthil Kumar
Nachimuthu Senthil Kumar
SSSumathi Sundaravadivelu
Sumathi Sundaravadivelu

25 October 2023 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
RARaghu Aswathy
Raghu Aswathy
SSSumathi Sundaravadivelu
Sumathi Sundaravadivelu